Renfu Pharmaceutical Group Brand Ranking
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Renfu Pharmaceutical Group

Renfu Pharmaceutical Group

Renfu Pharmaceutical Group Co., Ltd.
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

Renfu Pharmaceutical Group Co., Ltd. was established in 1993 and listed on the Shanghai Stock Exchange in 1997. It is the leading pharmaceutical industry enterprise in Hubei Province's National Enterprise Technology Center, a national technological innovation demonstration enterprise, and a leading enterprise in the internationalization of Chinese pharmaceutical enterprise preparations. Domestic narcotic drugs, steroid hormone drugs, Uyghur ethnic medicines have established a leading position in many sub-sectors.

The company is mainly based on the pharmaceutical industry and supplemented by the pharmaceutical business, and is steadily promoting internationalization. The pharmaceutical industry has achieved full dosage form production capacity of pharmaceutical intermediates-raw materials-pharmaceutical excipients-pharmaceutical preparations in the entire industry chain; pharmaceutical business adheres to the positioning of "comprehensive medical service supplier", lays out commercial networks, and achieves full regional coverage; internationalization has formed The full value chain capability of pharmaceuticals for global R&D, registration, production and sales has been exported to more than 80 products in more than 70 countries and regions around the world.

Based on innovative drugs, innovative preparations and high-end generic drugs with high clinical value, the company aims at cutting-edge fields and creates a first-class innovative R&D industrialization platform. R&D centers have been set up in Wuhan, Yichang, China, New Jersey, St. Louis and other places in the United States. The group has more than 500 projects under development, including more than 30 new drugs in Class I, and has obtained 778 authorized patents.

Renfu Pharmaceutical firmly adheres to the development strategy of "being a leader in the pharmaceutical market segment". Through the three strategic paths of "focusing, innovation, and internationalization", it gradually realizes the leap from international follow-up to leading, and creates global competitiveness. a world-class pharmaceutical company.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号